Barr Pharmaceuticals, Inc. (Inactive): SWOT Analysis & Company Profile

Business Review, January 2011, Pages: 30

Synopsis
Business Review’s Barr Pharmaceuticals, Inc. (Inactive) contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.

Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Barr Pharmaceuticals, Inc. (Inactive)’s business.

Business Review’s “Barr Pharmaceuticals, Inc. (Inactive) SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
- Examines and identifies key information and issues about (Barr Pharmaceuticals, Inc. (Inactive)) for business intelligence requirements
- Studies and presents Barr Pharmaceuticals, Inc. (Inactive)’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.

Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures

Key Highlights
Barr Pharmaceuticals, Inc. (Barr) is engaged in the development, manufacturing and marketing of generic and proprietary pharmaceuticals in generic pharmaceuticals and proprietary pharmaceuticals segments. Also, Barr is into the development and manufacturing of active pharmaceutical ingredients (API). The company’s operations are carried out in almost than 30 countries. Barr’s operations are mainly in North America and Europe. Barr Pharmaceuticals, Inc. markets its products in more than 30 countries, mainly including United States, Canada, Croatia, Germany, Poland and Russia. As on December 2008, the company was acquired by Teva Pharmaceutical Industries Limited. It is headquartered in Montvale, New Jersey, the US.

1 COMPANY OVERVIEW
1.1 Overview
1.2 Key Facts
2 BUSINESS OVERVIEW
2.1 Business Description
2.2 Operating Units
2.3 Major Products and Services
2.4 Key Employees
2.4.1 Key Employee Biographies
2.5 Locations and Subsidiaries
2.6 Key Competitors
3 SWOT ANALYSIS
3.1 Overview
3.2 Strengths
3.3 Weaknesses
3.4 Opportunities
3.5 Threats
4 FINANCIAL RATIOS
4.1 Capital Market Ratios
4.2 Annual Ratios
4.3 Interim Ratios
4.4 Ratio Charts
4.5 Share Data
5 FINANCIAL DEALS
5.1 Five Year Deal Analysis
6 NEWS AND EVENTS
6.1 News
6.2 Company History
7 Appendix
7.1 Research Methodology
7.2 Ratio Definitions
7.3 Additional Notes
7.4 Disclaimer

List of Tables
Table 1: Barr Pharmaceuticals, Inc. (Inactive) Key Facts
Table 2: Barr Pharmaceuticals, Inc. (Inactive) Major Products and Services
Table 3: Barr Pharmaceuticals, Inc. (Inactive) Key Employees
Table 4: Barr Pharmaceuticals, Inc. (Inactive) Key Employee Biographies
Table 5: Barr Pharmaceuticals, Inc. (Inactive) Locations
Table 6: Barr Pharmaceuticals, Inc. (Inactive) Subsidiaries
Table 7: Barr Pharmaceuticals, Inc. (Inactive) SWOT Analysis
Table 8: Barr Pharmaceuticals, Inc. (Inactive), Ratios Based On Current Share Price
Table 9: Barr Pharmaceuticals, Inc. (Inactive), Annual Ratios
Table 10: Barr Pharmaceuticals, Inc. (Inactive), Annual Ratios
Table 11: Barr Pharmaceuticals, Inc. (Inactive), Share Data
Table 12: Barr Pharmaceuticals, Inc. (Inactive) Financial Deals
Table 13: Barr Pharmaceuticals, Inc. (Inactive) History
Table 14: Ratio Definitions

List of Figures
Figure 1: Barr Pharmaceuticals, Inc. (Inactive), Ratio Charts

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Aerospace and Defense Industry - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Global UAV Payload Market 2012-2022
• Private Tutoring - Global Strategic Business Report
• Defense Robotics - Global Strategic Business Report